Integrative Health Solutions logoIntegrative HealthSOLUTIONS

Healthy Aging & Longevity

MOTS‑C

A mitochondrial-encoded peptide studied for its role in metabolic regulation and exercise capacity.

Man trail running at sunrise on a mountain ridge
Format
10mg vial — 2mg/mL, 5mL injectable
Price
$160 per vial
Route
Injectable
Evidence level
Preclinical
Regulatory status
Compounded
Testing
Recent Labs Recommended

Pricing reflects the compounded preparation and doctor review. Final therapy and dosing are determined only after your intake is reviewed.

Overview

Understanding MOTS-C

What is MOTS-C?

MOTS-C is a short peptide encoded by mitochondrial DNA rather than the nuclear genome. It belongs to a class of mitochondrial-derived peptides that have attracted research attention in metabolic and longevity science.

Format & administration

Typically prescribed as a subcutaneous injection several times per week rather than daily. Your doctor sets the schedule.

Testing posture

Your doctor determines the final testing requirements for MOTS-C after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.

How it works

How MOTS-C works

  1. 01Research has examined MOTS-C in relation to AMPK activation and cellular metabolic flexibility — the ability to shift between fuel sources — as well as its expression in response to metabolic stress such as exercise.
Show illustration: MOTS-c
MOTS-c: proposed mechanism, physiology, and reported clinical effects. Educational illustration — not a treatment guarantee.

What has been studied

Potential applications and evidence

These areas are commonly discussed within wellness-focused protocols. They are educational statements, not medical claims or guarantees of outcome.

Explored for endurance and exercise capacity
Discussed within metabolic health protocols
Potential support for cellular energy production
Studied in the context of healthy aging

Doctor-guided

A personalized approach

Your doctor determines the final testing requirements for MOTS-C after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.

Bloodwork status: Recent Labs Recommended

Commonly reviewed at baseline

  • Comprehensive metabolic panel (CMP)
  • Fasting glucose and A1c
  • Lipid panel
  • CBC

Follow-up & monitoring

Metabolic markers are commonly reviewed at 12 weeks alongside energy and body-composition changes.

Medication review

Your doctor reviews all prescriptions, supplements, and over-the-counter medications during intake before anything is prescribed.

Format & dosing

Typically prescribed as a subcutaneous injection several times per week rather than daily. Your doctor sets the schedule.

Safety

What patients should know

  • Not an FDA-approved product; compounded per prescription. Review diabetes medications and metabolic conditions during intake.

Who may not be a candidate

  • Pregnancy or nursing
  • Active malignancy without oncology clearance
  • Known hypersensitivity to the preparation

Regulatory status: Compounded. Evidence level: Preclinical. Eligibility, dosing, laboratory requirements, and follow-up care are determined exclusively by a licensed doctor after review of your history.

Common questions

Frequently asked questions

Ready when you are

Find out what your body is actually asking for.

Fill out a short intake form and our care team will build a plan grounded in your labs — not a guess from a supplement aisle.